Biofabrication Market Will Surpass US$ 31.69 Billion at 28.3% CAGR Growth Forecasted Period 2025-2034

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:
• 𝐓𝐡𝐞 𝐛𝐢𝐨𝐟𝐚𝐛𝐫𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 2.63 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024.

• 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐞𝐱𝐩𝐚𝐧𝐝 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 28.3% 𝐟𝐫𝐨𝐦 2025 𝐭𝐨 2034.

• 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐭𝐨 𝐔𝐒𝐃 31.69 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2034.

𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Biofabrication involves utilizing biological materials and living cells to construct structures, devices, or products with practical uses. It merges biology, engineering, and materials science to create intricate, tailor-made tissues, organs, or various biological structures. Biofabrication presents great promise in areas such as regenerative medicine, tissue engineering, and eco-friendly manufacturing. It provides methods for producing bio-based products, minimizing waste, and enhancing medical therapies.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/biofabrication-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:
Rising global demand for regenerative therapies to treat injured organs from chronic illnesses or traumatic injuries drives the growth of the biofabrication market. Moreover, an increase in capital investments and government funding within the sector boosts the number of participants in the market and drives the need for fabrication methods.

𝐊𝐞𝐲 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬:
As the market expands, competition is expected to increase with the involvement of numerous businesses. Some of the major players participating in the biofabrication market are:
• Organovo Holdings, Inc.
• Cellink
• Allevi
• Aspect Biosystems
• Prellis Biologics
• Tissue Regenix
• NanoScribe
• Pandorum International Inc.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/biofabrication-market/request-for-discount-pricing

𝐁𝐢𝐨𝐟𝐚𝐛𝐫𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:
• Based on technology, the 3D bioprinting segment is anticipated to experience substantial growth with a significant CAGR in the global market during the forecast period. This growth is attributed to advances in technology that have enhanced precision and efficiency.

• The drug testing segment, by application, accounted for the largest revenue share of the market in 2023 due to an increase in pipeline drugs.

• In 2023, North America dominated the global biofabrication market due to the increasing number of hospitals, the presence of major players.

• The biofabrication market in India is projected for substantial growth due to the increasing number of pipeline drugs for trials.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:
The market is mainly segmented based on technology, material type, application, end user, and region. Based on technology analysis, the 3D bioprinting segment is anticipated to witness the highest CAGR in the global market over the projection period. This expansion is due to the increasing technological innovations that have improved the accuracy and effectiveness of bioprinting, enabling the development of intricate tissue structures for medical, pharmaceutical, and cosmetic uses.

Furthermore, according to the application analysis, the drug testing segment is anticipated to lead the global market over the forecasted period. This expansion is fueled by the increasing demand for more precise, predictive representations of human tissues and organs to evaluate drug effectiveness and safety.
By Technology Outlook (Revenue - USD billion, 2020-2034)
• 3D Bioprinting
• Tissue Engineering
• Biomaterial Fabrication
• Other

By Material Type (Revenue - USD billion, 2020-2034)
• Bioinks
• Biological Cells
• Biomaterials
• Others

By Application (Revenue - USD billion, 2020-2034)
• Regenerative Medicine
• Durg Testing
• Cosmetic Treatment

By End User (Revenue - USD billion, 2020-2034)
• Academic and Research Institutes
• Biotechnology and Pharmaceutical Companies
• Hospitals and Specialty Clinics

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/biofabrication-market

𝐂𝐨𝐮𝐧𝐭𝐫𝐲-𝐖𝐢𝐬𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Brain Machine Interface Market:
https://www.polarismarketresearch.com/industry-analysis/brain-machine-interface-market

Immunotherapy Drugs Market:
https://www.polarismarketresearch.com/industry-analysis/immunotherapy-drugs-market

Asia Pacific SGLT2 Inhibitors Market:
https://www.polarismarketresearch.com/industry-analysis/asia-pacific-sglt2-inhibitors-market

FEP Heat Shrink Medical Tubing Market:
https://www.polarismarketresearch.com/industry-analysis/fep-heat-shrink-medical-tubing-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
𝐋𝐢𝐤𝐡𝐢𝐥 𝐆
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.